(Q42116708)

16 October 2017

title

Enhanced expression of high-affinity interleukin-2 receptors in scleroderma: Possible role for IL-6 (English)

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

10 November 2022

author name string

M. B. Kahaleh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728984

10 November 2022

T. G. Yin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728984

10 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728984

10 November 2022

publication date

1 January 1992

1 reference

full work available at URL

16 October 2017

https://api.elsevier.com/content/article/PII:009012299290028M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

https://api.elsevier.com/content/article/PII:009012299290028M?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Clinical Immunology and Immunopathology

10 November 2022

published in

1 reference

16 October 2017

volume

62

1 reference

16 October 2017

issue

1 Pt 1

1 reference

16 October 2017

page(s)

97-102

1 reference

Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations

16 October 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Enhanced production of interleukin-2 in patients with progressive systemic sclerosis. Hyperactivity of CD4-positive T cells?

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

A modified scleroderma skin scoring method

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

T cell growth factor receptors. Quantitation, specificity, and biological relevance

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Abnormalities of immunoregulation in progressive systemic sclerosis. Evidence for excess helper-cell function and altered B-cell function

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Proto-oncogene expression and nuclear factor specifically bound to c-myc gene in peripheral blood mononuclear cells from progressive systemic sclerosis patients as the indicator of clinical activity

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Molecular analysis of the interleukin-2 system

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Expression of interleukin 2 receptors on activated human B cells

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Significance of T-lymphocytes in wound healing

10 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

In vitro and in vivo evidence that autoimmune reactivity to collagen develops spontaneously in Schistosoma mansoni-infected mice

10 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Immunoregulation of lung fibroblast growth: alteration in asbestos-induced pulmonary fibrosis

10 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis

10 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90028-M

10 November 2022

Identifiers

1 reference

16 October 2017

1 reference